MSH Capital Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,224
| Closed | -$254K | – | 229 |
|
|
2024
Q3 | $254K | Sell |
6,224
-181
| -3% | -$7.4K | 0.08% | 205 |
|
|
2024
Q2 | $247K | Sell |
6,405
-519
| -7% | -$20K | 0.08% | 201 |
|
|
2024
Q1 | $297K | Sell |
6,924
-824
| -11% | -$35.3K | 0.1% | 175 |
|
|
2023
Q4 | $287K | Sell |
7,748
-536
| -6% | -$19.9K | 0.11% | 169 |
|
|
2023
Q3 | $300K | Hold |
8,284
| – | – | 0.12% | 169 |
|
|
2023
Q2 | $295K | Sell |
8,284
-300
| -3% | -$10.7K | 0.11% | 178 |
|
|
2023
Q1 | $305K | Sell |
8,584
-240
| -3% | -$8.54K | 0.13% | 159 |
|
|
2022
Q4 | $310K | Sell |
8,824
-520
| -6% | -$18.3K | 0.14% | 149 |
|
|
2022
Q3 | $275K | Buy |
9,344
+19
| +0.2% | +$559 | 0.14% | 155 |
|
|
2022
Q2 | $507K | Sell |
9,325
-480
| -5% | -$26.1K | 0.24% | 106 |
|
|
2022
Q1 | $534K | Buy |
9,805
+436
| +5% | +$23.7K | 0.22% | 106 |
|
|
2021
Q4 | $516K | Buy |
+9,369
| New | +$516K | 0.23% | 102 |
|